spinal muscular atrophy (SMA) 脊髓肌肉萎縮症

spinal muscular atrophy (SMA)
繁：脊髓肌肉萎縮症
简：脊髓肌肉萎缩症

脊髓肌肉萎縮症本是無藥可醫的罕見疾病，患者需要長期使用呼吸機，直至去年底，美國推出一種新藥物「Spinraza」，可改善患者四肢活動，成效顯著，但每年藥費高達六百萬元，大部分患者難以承擔。

肌萎症患者求新藥 林鄭接信願爭取（2017年10月9日）。星島日報，取自 http://std.stheadline.com/daily/news-content.php?id=1677852&target=2

Josy Chow Pui-shan, who was born with spinal muscular atrophy (SMA), a genetic disorder that gradually destroys physical abilities such as walking and breathing, urged the government to introduce nusinersen, marketed as Spinraza, the first approved drug for SMA by the US Food and Drug Administration.

Using only two fingers, Hong Kong girl types 22-page proposal calling for life-saving muscle drug. (2017, October 8). South China Morning Post. Retrieved from http://www.scmp.com/news/hong-kong/health-environment/article/2114344/using-only-two-fingers-hong-kong-girl-types-22